Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H9PT
|
|||
| Former ID |
DNCL003713
|
|||
| Drug Name |
RG3638
|
|||
| Synonyms |
Onartuzumab
Click to Show/Hide
|
|||
| Indication | Gastric adenocarcinoma [ICD-11: 2B72] | Phase 3 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y] | Phase 3 | [1] | ||
| Company |
Roche
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02488330) An Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1815). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.